Your browser doesn't support javascript.
loading
A putative role for Discoidin Domain Receptor 1 in cancer chemoresistance.
Ambrogio, Chiara; Darbo, Elodie; Lee, Sam W; Santamaría, David.
Afiliação
  • Ambrogio C; a Department of Medical Oncology , Dana-Farber Cancer Institute , Boston , MA , USA.
  • Darbo E; b University of Bordeaux , INSERM U1218, ACTION Laboratory, Centre de Bioinformatique de Bordeaux (CBiB) , Bordeaux , France.
  • Lee SW; c Cutaneous Biology Research Center , Massachusetts General Hospital and Harvard Medical School , Charlestown , MA , USA.
  • Santamaría D; d University of Bordeaux , INSERM U1218, ACTION Laboratory, IECB , Pessac , France.
Cell Adh Migr ; 12(4): 394-397, 2018.
Article em En | MEDLINE | ID: mdl-29505315
ABSTRACT
The Discoidin Domain Receptor 1 (DDR1) receptor tyrosine kinase performs pleiotropic functions in the control of cell adhesion, proliferation, survival, migration, and invasion. Aberrant DDR1 function as a consequence of either mutations or increased expression has been associated with various human diseases including cancer. Pharmacological inhibition of DDR1 results in significant therapeutic benefit in several pre-clinical cancer models. Here, we discuss the potential implication of DDR1-dependent pro-survival functions in the development of cancer resistance to chemotherapeutic regimens and speculate on the molecular mechanisms that might mediate such important feature.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Receptor com Domínio Discoidina 1 / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Receptor com Domínio Discoidina 1 / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article